Intravitreal Bevacizumab Proves Effective For Choroidal Neovascularization注射bevacizumab证明有效的脉络膜新生血管
Thursday, May 15th, 2008 周四, 2008年5月15日Researchers at the University of Bonn and Hospital Saarbrücken find Intravitreal bevacizumab a solution to choroidal neovascularization patients to secondary pseudoxanthoma elasticum.研究人员在波恩大学和医院萨尔布吕肯找到注射bevacizumab解决脉络膜新生血管的病人中学弹性纤维假黄瘤。 Robert P. Finger and his colleagues have tested the study to 15 patients.罗伯特页手指和他的同事测试了研究,以15例。 All these patients had active CNV secondary on pseudoxanthoma elasticum.所有这些病人积极cnv中学对弹性纤维假黄瘤。
































